Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.
Environmental concerns play a major role in the lives of our older adults, and pollution can shorten lifespans, decrease independence, and affect overall health.